Treatment of Toxoplasmosis
The recommended first-line treatment for toxoplasmosis is the combination of pyrimethamine plus sulfadiazine with leucovorin (folinic acid) supplementation. 1, 2
Treatment Regimens Based on Clinical Scenario
Non-pregnant Immunocompetent Adults with Active Toxoplasmosis
- First-line therapy:
- Pyrimethamine: Loading dose of 2 mg/kg/day orally divided twice daily for first 2 days, then 1 mg/kg/day daily (maximum 75 mg/day) 1
- Sulfadiazine: 100 mg/kg/day orally divided twice daily (maximum 4-6 g/day) 1
- Leucovorin (folinic acid): 10-25 mg orally three times weekly (mandatory to prevent bone marrow suppression) 1, 2
- Duration: 4-6 weeks, continuing for 1-2 weeks after resolution of clinical signs and symptoms 1
HIV/Immunocompromised Patients with Toxoplasmic Encephalitis (TE)
- Acute treatment:
- Same regimen as above but often higher doses
- Duration: At least 6 weeks, until clinical and radiological improvement 1
- Secondary prophylaxis (maintenance therapy):
Pregnant Women with Acute Toxoplasmosis
Before 18 weeks of pregnancy:
After 18 weeks of pregnancy or confirmed fetal infection:
Congenital Toxoplasmosis
- Treatment duration:
- 6 months for asymptomatic or moderately symptomatic cases
- 12 months for severely symptomatic cases 1
- Dosing:
- Pyrimethamine: 2 mg/kg/day for 2 days, then 1 mg/kg/day
- Sulfadiazine: 100 mg/kg/day divided twice daily
- Leucovorin: 10 mg three times weekly 1
Alternative Treatment Regimens
For patients who cannot tolerate sulfadiazine:
Pyrimethamine + clindamycin + leucovorin:
Trimethoprim-sulfamethoxazole (TMP-SMX):
- 5 mg/kg trimethoprim plus 25 mg/kg sulfamethoxazole twice daily 1
- Effective for both treatment and prophylaxis
Atovaquone-based regimens:
- Atovaquone 1,500 mg orally twice daily with meals
- Can be combined with pyrimethamine + leucovorin or used alone in patients intolerant to both pyrimethamine and sulfadiazine 1
Monitoring During Treatment
- Weekly complete blood count while on daily pyrimethamine (risk of bone marrow suppression) 1, 2
- Monthly CBC when on less frequent dosing 1
- Ophthalmologic follow-up every 2-3 weeks during active treatment for ocular toxoplasmosis 1
- Clinical and radiological response evaluation after 6 weeks of treatment 1
Important Precautions
Pyrimethamine warnings:
Drug interactions:
Prophylaxis Recommendations
Primary prophylaxis for HIV patients:
Secondary prophylaxis after treated toxoplasmosis:
Prevention Measures
- Cook meat thoroughly to internal temperature of 165°F (73.8°C) 1
- Wash hands after handling raw meat, gardening, or contact with soil 1
- Wash fruits and vegetables thoroughly before eating raw 1
- For cat owners: change litter box daily (preferably by HIV-negative, non-pregnant person) 1
The most recent evidence shows that early treatment initiation significantly reduces transmission rates and clinical manifestations, particularly when started within 3 weeks of infection 4, 5, emphasizing the importance of prompt diagnosis and treatment.